Zhang Yi, Tedja Roslyn, Millman Michael, Wong Terrence, Fox Alexandra, Chehade Hussein, Gershater Meyer, Adzibolosu Nicholas, Gogoi Radhika, Anderson Matthew, Rutherford Thomas, Zhang Zhenggang, Chopp Michael, Mor Gil, Alvero Ayesha B
Neurology, Henry Ford Health, Detroit, MI.
C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI.
bioRxiv. 2023 Nov 10:2023.11.07.566022. doi: 10.1101/2023.11.07.566022.
Chromobox protein homolog 7 (CBX7), a member of the Polycomb repressor complex, is a potent epigenetic regulator and gene silencer. Our group has previously reported that CBX7 functions as a tumor suppressor in ovarian cancer cells and its loss accelerated formation of carcinomatosis and drove tumor progression in an ovarian cancer mouse model. The goal of this study is to identify specific signaling pathways in the ovarian tumor microenvironment that down-regulate CBX7. Given that adipocytes are an integral component of the peritoneal cavity and the ovarian tumor microenvironment, we hypothesize that the adipose microenvironment is an important regulator of CBX7 expression.
Using conditioned media from human omental explants, we found that adipose-derived exosomes mediate CBX7 downregulation and enhance migratory potential of human ovarian cancer cells. Further, we identified adipose-derived exosomal miR-421 as a novel regulator of CBX7 expression and the main effector that downregulates CBX7.
In this study, we identified miR-421 as a specific signaling pathway in the ovarian tumor microenvironment that can downregulate CBX7 to induce epigenetic change in OC cells, which can drive disease progression. These findings suggest that targeting exosomal miR-421 may curtail ovarian cancer progression.
染色体框蛋白同源物7(CBX7)是多梳抑制复合物的成员,是一种强大的表观遗传调节因子和基因沉默子。我们小组之前报道过,CBX7在卵巢癌细胞中起肿瘤抑制作用,其缺失加速了癌瘤形成,并在卵巢癌小鼠模型中推动肿瘤进展。本研究的目的是确定卵巢肿瘤微环境中下调CBX7的特定信号通路。鉴于脂肪细胞是腹膜腔和卵巢肿瘤微环境的重要组成部分,我们推测脂肪微环境是CBX7表达的重要调节因子。
使用来自人网膜外植体的条件培养基,我们发现脂肪来源的外泌体介导CBX7下调,并增强人卵巢癌细胞的迁移潜能。此外,我们确定脂肪来源的外泌体miR-421是CBX7表达的新型调节因子,也是下调CBX7的主要效应物。
在本研究中,我们确定miR-421是卵巢肿瘤微环境中一条可下调CBX7以诱导卵巢癌细胞表观遗传变化从而推动疾病进展的特定信号通路。这些发现表明,靶向外泌体miR-421可能会抑制卵巢癌进展。